Brief: U.S. FDA Gives Green Light To Molecure's Flagship Program

Molecure SA

24/07/2023 14:29

July 24 (Reuters) - Molecure SA  MOCP.WA :
    * U.S. FOOD AND DRUG ADMINISTRATION GIVES GREEN LIGHT TO
MOLECURE'S FLAGSHIP PROGRAM - PHASE II CLINICAL TESTING OF
OATD-01 IS READY FOR LAUNCH
    * MOLECURE SA - FIRST PULMONARY SARCOIDOSIS PATIENTS IN THIS
PHASE
II STUDY ARE SCHEDULED TO BEGIN RECEIVING TREATMENT IN Q4 2O23
    * MOLECURE SA - EXPECT TO CONCLUDE PHASE II CLINICAL STUDIES
IN
MID-2025 WITH PUBLICATION OF A REPORT ANALYZING HEADLINE DATA

Source text for Eikon:  ID:nGNX6lNnhH 
Further company coverage:  MOCP.WA 

 ((Reuters.Briefs@thomsonreuters.com;))